USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Future Growth Potential Enhanced by Expanding Clinical Indications and Technological Advancements
19-Sep-2023
North America
Market Research
K94B-01-00-00-00
HC_2023_153
This Frost & Sullivan research service analyzes the neuromodulation market, including the market landscape of major neuromodulation technologies and regions, and the market share of key participants. It also examines new applications, technologies, and trends in the industry. The study provides market estimates and forecasts from 2021 to 2027 and highlights new opportunities in neuromodulation devices, innovations, and unaddressed markets.
The neuromodulation devices market is highly competitive as new innovative technologies are constantly introduced and many new start-ups are entering through new application areas and disease indications. Furthermore, advances in sensing, neuroimaging, artificial intelligence, virtual care, and telemedicine are positively impacting market growth.
Major applications for neuromodulation technologies include deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation, and cochlear implants, which are covered in this study, as are various neuromodulation techniques and devices are used for different disease areas—movement disorders, neurological diseases, and chronic pain, among others.
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Neuromodulation Devices Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Segmentation
Key Competitors
Key Competitors (continued)
Growth Metrics
Growth Drivers
Growth Restraints
Device Challenges
New Product Approvals
Investment Scenario
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Product
Revenue Forecast by Region
Revenue Forecast Analysis
Pricing Trends and Forecast Analysis
Competitive Environment
Revenue Share
Revenue Share (continued)
Revenue Share Analysis
Applications
Applications (Continued)
Key Indications and Prevalence
Key Indications and Prevalence (continued)
End User
Digital Health Integration in Neuromodulation
Digital Health Integration in Neuromodulation (continued)
Personalization
New Technologies
Non-invasive Technologies
Future Trends
Growth Metrics
Revenue Forecast
Revenue Forecast by Product
Forecast Analysis by Product
Growth Metrics
Revenue Forecast
Revenue Forecast by Product
Forecast Analysis by Product
Growth Metrics
Revenue Forecast
Revenue Forecast by Product
Forecast Analysis by Product
Growth Metrics
Revenue Forecast
Revenue Forecast by Product
Forecast Analysis by Product
Growth Metrics
Revenue Forecast
Revenue Forecast by Product
Forecast Analysis by Product
Growth Opportunity 1: Expanding Clinical Indications
Growth Opportunity 1: Expanding Clinical Indications (continued)
Growth Opportunity 2: Digitalization
Growth Opportunity 2: Digitalization (continued)
Growth Opportunity 3: Non-invasive/Minimally Invasive Solutions
Growth Opportunity 3: Non-invasive/Minimally Invasive Solutions (continued)
Growth Opportunity 4: Neuromodulation Personalization
Growth Opportunity 4: Neuromodulation Personalization (continued)
Growth Opportunity 5: Emerging Markets
Growth Opportunity 5: Emerging Markets (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
List of Figures
- Neuromodulation Devices: Growth Metrics, Global, 2022
- Neuromodulation Devices: Growth Drivers, Global, 2023–2027
- Neuromodulation Devices: Growth Restraints, Global, 2023–2027
- Neuromodulation Devices: Challenges, Global, 2022
- Neuromodulation Devices: US FDA-approved Devices, Global, 2021–June 2023
- Neuromodulation Devices: Recent Investments, Global
- Neuromodulation Devices: Revenue Forecast, Global, 2020–2027
- Neuromodulation Devices: Revenue Forecast by Product, Global, 2020–2027
- Neuromodulation Devices: Revenue Forecast by Region, Global, 2020–2027
- Neuromodulation Devices: Revenue Share of Top Participants, Global, 2022
- Neuromodulation Devices: Application Areas for Neuromodulation, Global, 2022
- Neuromodulation Devices: Key Indications and Prevalence, Global, 2022
- Neuromodulation Devices: Non-invasive Technologies, Global, 2022
- Neuromodulation Devices: Growth Metrics, North America, 2022
- Neuromodulation Devices: Revenue Forecast, North America, 2020–2027
- Neuromodulation Devices: Revenue Forecast by Product, North America, 2020–2027
- Neuromodulation Devices: Growth Metrics, Europe, 2022
- Neuromodulation Devices: Revenue Forecast, Europe, 2020–2027
- Neuromodulation Devices: Revenue Forecast by Product, Europe, 2020–2027
- Neuromodulation Devices: Growth Metrics, Asia-Pacific, 2022
- Neuromodulation Devices: Revenue Forecast, Asia-Pacific, 2020–2027
- Neuromodulation Devices: Revenue Forecast by Product, Asia-Pacific, 2020–2027
- Neuromodulation Devices: Growth Metrics, MENASA, 2022
- Neuromodulation Devices: Revenue Forecast, MENASA, 2020–2027
- Neuromodulation Devices: Revenue Forecast by Product, MENASA, 2020–2027
- Neuromodulation Devices: Growth Metrics, Latin America and the Caribbean, 2022
- Neuromodulation Devices: Revenue Forecast, Latin America and the Caribbean, 2020–2027
- Neuromodulation Devices: Revenue Forecast by Product, Latin America and the Caribbean, 2020–2027
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
15 Sep 2026 | Global | Market Research
Vendor Profiles: Advanced Wound Care Management Market, Global, 2025
The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...
11 Sep 2026 | Global | Frost Radar
Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026
Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...
07 Sep 2026 | Global | Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...
28 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| Author | Utkarsha soundankar |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Neuromodulation Industry |
| Keyword 2 | Neuromodulation Trends |
| Keyword 3 | Neuromodulation Market Analysis |
| List of Charts and Figures | Neuromodulation Devices: Growth Metrics, Global, 2022~ Neuromodulation Devices: Growth Drivers, Global, 2023–2027~ Neuromodulation Devices: Growth Restraints, Global, 2023–2027~ Neuromodulation Devices: Challenges, Global, 2022~ Neuromodulation Devices: US FDA-approved Devices, Global, 2021–June 2023~ Neuromodulation Devices: Recent Investments, Global~ Neuromodulation Devices: Revenue Forecast, Global, 2020–2027~ Neuromodulation Devices: Revenue Forecast by Product, Global, 2020–2027~ Neuromodulation Devices: Revenue Forecast by Region, Global, 2020–2027~ Neuromodulation Devices: Revenue Share of Top Participants, Global, 2022~ Neuromodulation Devices: Application Areas for Neuromodulation, Global, 2022~ Neuromodulation Devices: Key Indications and Prevalence, Global, 2022~ Neuromodulation Devices: Non-invasive Technologies, Global, 2022~ Neuromodulation Devices: Growth Metrics, North America, 2022~ Neuromodulation Devices: Revenue Forecast, North America, 2020–2027~ Neuromodulation Devices: Revenue Forecast by Product, North America, 2020–2027~ Neuromodulation Devices: Growth Metrics, Europe, 2022~ Neuromodulation Devices: Revenue Forecast, Europe, 2020–2027~ Neuromodulation Devices: Revenue Forecast by Product, Europe, 2020–2027~ Neuromodulation Devices: Growth Metrics, Asia-Pacific, 2022~ Neuromodulation Devices: Revenue Forecast, Asia-Pacific, 2020–2027~ Neuromodulation Devices: Revenue Forecast by Product, Asia-Pacific, 2020–2027~ Neuromodulation Devices: Growth Metrics, MENASA, 2022~ Neuromodulation Devices: Revenue Forecast, MENASA, 2020–2027~ Neuromodulation Devices: Revenue Forecast by Product, MENASA, 2020–2027~ Neuromodulation Devices: Growth Metrics, Latin America and the Caribbean, 2022~ Neuromodulation Devices: Revenue Forecast, Latin America and the Caribbean, 2020–2027~ Neuromodulation Devices: Revenue Forecast by Product, Latin America and the Caribbean, 2020–2027~ |
| Podcast | No |
| WIP Number | K94B-01-00-00-00 |
Global Neuromodulation Devices Market, Forecast to 2027
$4,950.00
Special Price $3,712.50 save 25 %